TAVNEOS caps 10 mg fl 180 pce
7680667720027
CH-66772
L04AJ05
07.15.0.
Reimbursement limitations:
TAVNEOS
Avant le début du traitement, une garantie de prise en charge des coûts par l'assurance …
1 / 3
google
Details
- Product number
- 6677201
- CPT
- -
- Packaging group
- 180
- Unit
- Kapsel(n)
- Composition
- avacopanum 10 mg, macrogolglyceroli hydroxystearas 245 mg, macrogolum 4000, Kapselhülle: E 172 (rubrum), E 172 (flavum), E 171, gelatina, polysorbatum 80, Drucktinte: E 172 (nigrum), pro capsula.
Articles (1)
Tavneos 10 mg, Hartkapseln
Kapseln
180
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
245.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 5891.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Vifor Fresenius Medical Care
9014 St. Gallen
Authorization information
- Swissmedic authorization number
- 66772
- Drug name
- Tavneos, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L04AJ05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/09/2022
- Authorization expiration date
- 18/09/2027
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TAVNEOS caps 10 mg fl 180 pce
- Description (DE)
- TAVNEOS Kaps 10 mg Fl 180 Stk
- Market launch
- 19/09/2022
- Narcotic (BTM)
- No